Specific reactions between purified HIV-1 particles and CD4+cell membrane fragments in a cell-free system of virus fusion or entry

Microbes and Infection

Volumn 6, Issue 5, 2004, Pages 421-428

  Harada, Takayuki ^a   Tatsumi, Masashi ^a   Takahashi, Hidehiro ^a   Sata, Tetsutaro ^a   Kurata, Takeshi ^a   Kojima, Asato ^a  

^a NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

Author keywords

Cell free reaction; HIV 1 entry; Membrane fusion; p24 Release

Indexed keywords

CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CXCR4; GAG PROTEIN;

ARTICLE; CELL CULTURE; CELL FREE SYSTEM; CELL FUSION; COCULTURE; HELA CELL; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IN VITRO STUDY; MEMBRANE FUSION; NONHUMAN; PRIORITY JOURNAL; PROTEIN INDUCTION; PROTEIN SECRETION; T LYMPHOCYTE; TEMPERATURE DEPENDENCE; VIRION;

ANTIGENS, CD4; ANTIVIRAL AGENTS; CELL LINE; CELL MEMBRANE; CELL-FREE SYSTEM; CHEMOKINES, CXC; GENE PRODUCTS, ENV; HIV CORE PROTEIN P24; HIV-1; HUMANS; MACROPHAGE INFLAMMATORY PROTEIN-1; RECEPTORS, CCR5; RECEPTORS, CXCR4; RECEPTORS, HIV;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 1942517386     PISSN: 12864579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.micinf.2004.02.002     Document Type: Article

References (42)

1. Doms R.W. Beyond receptor expression: the influence of receptor conformation, density, and affinity in HIV-1 infection. Virology. 276:2000;229-237.
2. Freed E.O., Martin M.A. HIVs and their replication. Knipe D.M., Howley P.M. Fields Virology. 2001;1971-2041 Lippincott Williams & Wilkins, Philadelphia.
3. Kimpton J., Emerman M. Detection of replication-competent and pseudotyped human immunodeficiency virus with a sensitive cell line on the basis of activation of an integrated β-galactosidase gene. J. Virol. 66:1992;2232-2239.
4. Adachi A., Kawamura M., Tokunaga K., Sakai H. Methods for HIV/SIV gene analysis. Adolph K.W. Viral Genome Methods. 1996;44-53 CRC Press Inc. Boca Raton.
5. Schmidtmayerova H., Alfano M., Nuovo G., Bukrinsky M. Human immunodeficiency virus type 1 T-lymphotropic strains enter macrophages via a CD4- and CXCR4-mediated pathway: replication is restricted at a postentry level. J. Virol. 72:1998;4633-4642.
6. Dimitrov D.S., Golding H., Blumenthal R. Initial stages of HIV-1 envelope glycoprotein-mediated cell fusion monitored by a new assay based on redistribution of fluorescent dyes. AIDS Res. Hum. Retroviruses. 7:1991;799-805.
7. + cells: implications for inhibition of virus infection and initial steps of virus entry into cells. Virology. 187:1992;398-406.
8. Duzgunes N., Larsen C.E., Konopka K., Alford D.R., Young L.J., McGraw T.P., Davis B.R., Nir S., Jennings M. Fusion of HIV-1 and SIVmac with liposomes and modulation of HIV-1 infectivity. Adv. Exp. Med. Biol. 300:1991;167-189.
9. Raviv Y., Viard M., Bess J. Jr, Blumenthal R. Quantitative measurement of fusion of HIV-1 and SIV with cultured cells using photosensitized labeling. Virology. 293:2002;243-251.
10. Cavrois M., De Noronha C., Greene W.C. A sensitive and specific enzyme-based assay detecting HIV-1 virion fusion in primary T lymphocytes. Nat. Biotechnol. 20:2002;1151-1154.
11. Munk C., Brandt S.M., Lucero G., Landau N.R. A dominant block to HIV-1 replication at reverse transcription in simian cells. Proc. Natl. Acad. Sci. USA. 99:2002;13843-13848.
12. Shen H., Cheng T., Preffer F.I., Dombkowski D., Tomasson M.H., Golan D.E., Yang O., Hofmann W., Sodroski J.G., Luster A.D., Scadden D.T. Intrinsic human immunodeficiency virus type 1 resistance of hematopoietic stem cells despite coreceptor expression. J. Virol. 73:1999;728-737.
13. Moriuchi H., Moriuchi M., Arthos J., Hoxie J., Fauci A.S. Promonocytic U937 subclones expressing CD4 and CXCR4 are resistant to infection with and cell-to-cell fusion by T-cell-tropic human immunodeficiency virus type 1. J. Virol. 71:1997;9664-9671.
14. + cells express CXCR4 and its ligand stromal cell-derived factor-1. Implications for infection by T-cell tropic human immunodeficiency virus. Blood. 94:1999;62-73.
15. Paxton W.A., Martin S.R., Tse D., O'Brien T.R., Skurnick J., VanDevanter N.L., Padian N., Braun J.F., Kotler D.P., Wolinsky S.M., Koup R.A. Relative resistance to HIV-1 infection of CD4 lymphocytes from persons who remain uninfected despite multiple high-risk sexual exposures. Nat. Med. 2:1996;412-417.
16. +, T-cell clones correlates with the clinical state of human immunodeficiency virus type 1 (HIV-1)-infected individuals and may be responsible for blocking infection with non-syncytium-inducing HIV-1 in vitro. J. Virol. 72:1998;876-881.
17. Cole S.W., Jamieson B.D., Zack J.A. cAMP up-regulates cell surface expression of lymphocyte CXCR4: implications for chemotaxis and HIV-1 infection. J. Immunol. 162:1999;1392-1400.
18. Popik W., Hesselgesser J.E., Pitha P.M. Binding of human immunodeficiency virus type 1 to CD4 and CXCR4 receptors differentially regulates expression of inflammatory genes and activates the MEK/ERK signaling pathway. J. Virol. 72:1998;6406-6413.
19. Fackler O.T., Peterlin B.M. Endocytic entry of HIV-1. Curr. Biol. 10:2000;1005-1008.
20. Guyader M., Kiyokawa E., Abrami L., Turelli P., Trono D. Role for human immunodeficiency virus type 1 membrane cholesterol in viral internalization. J. Virol. 76:2002;10356-10364.
21. Marechal V., Clavel F., Heard J.M., Schwartz O. Cytosolic Gag p24 as an index of productive entry of human immunodeficiency virus type 1. J. Virol. 72:1998;2208-2212.
22. Marechal V., Prevost M.C., Petit C., Perret E., Heard J.M., Schwartz O. Human immunodeficiency virus type 1 entry into macrophages mediated by macropinocytosis. J. Virol. 75:2001;11166-11177.
23. Sieczkarski S.B., Whittaker G.R. Dissecting virus entry via endocytosis. J. Gen. Virol. 83:2002;1535-1545.
24. Tsunetsugu-Yokota Y., Akagawa K., Kimoto H., Suzuki K., Iwasaki M., Yasuda S., Hausser G., Hultgren C., Meyerhans A., Takemori T. Monocyte-derived cultured dendritic cells are susceptible to human immunodeficiency virus infection and transmit virus to resting T cells in the process of nominal antigen presentation. J. Virol. 69:1995;4544-4547.
25. + cell clone 1-10 (MAGIC5). Antimicrob. Agents Chemother. 45:2001;495-501.
26. Pear W.S., Nolan G.P., Scott M.L., Baltimore D. Production of high-titer helper-free retroviruses by transient transfection. Proc. Natl. Acad. Sci. USA. 90:1993;8392-8396.
27. Shibata R., Kawamura M., Sakai H., Hayami M., Ishimoto A., Adachi A. Generation of a chimeric human and simian immunodeficiency virus infectious to monkey peripheral blood mononuclear cells. J. Virol. 65:1991;3514-3520.
28. Adachi A., Gendelman H.E., Koenig S., Folks T., Willey R., Rabson A., Martin M.A. Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone. J. Virol. 59:1986;284-291.
29. Koyanagi Y., Miles S., Mitsuyasu R.T., Merrill J.E., Vinters H.V., Chen I.S.Y. Dual infection of the central nervous system by AIDS viruses with distinct cellular tropisms. Science. 236:1987;819-822.
30. Rose J.K., Bergmann J.E. Altered cytoplasmic domains affect intracellular transport of the vesicular stomatitis virus glycoprotein. Cell. 34:1983;513-524.
31. Tokunaga K., Ikuta K., Adachi A., Matsuda M., Kurata T., Kojima A. The cellular kinase binding motifs (PxxP and RR) in human immunodeficiency virus type 1 Nef protein are dispensable for producer-cell-dependent enhancement of viral entry. Virology. 257:1999;285-289.
32. Bess J.W. Jr, Gorelick R.J., Bosche W.J., Henderson L.E., Arthur L.O. Microvesicles are a source of contaminating cellular proteins found in purified HIV-1 preparations. Virology. 230:1997;134-144.
33. Dettenhofer M., Yu X.F. Highly purified human immunodeficiency virus type 1 reveals a virtual absence of Vif in virions. J. Virol. 73:1999;1460-1467.
34. Gluschankof P., Mondor I., Gelderblom H.R., Sattentau Q.J. Cell membrane vesicles are a major contaminant of gradient-enriched human immunodeficiency virus type 1 preparations. Virology. 230:1997;125-133.
35. Amara A., Gall S.L., Schwartz O., Salamero J., Montes M., Loetscher P., Baggiolini M., Virelizier J.L., Arenzana-Seisdedos F. HIV coreceptor downregulation as antiviral principle: SDF-1α-dependent internalization of the chemokine receptor CXCR4 contributes to inhibition of HIV replication. J. Exp. Med. 186:1997;139-146.
36. Alkhatib G., Locati M., Kennedy P.E., Murphy P.M., Berger E.A. HIV-1 coreceptor activity of CCR5 and its inhibition by chemokines: independence from G protein signaling and importance of coreceptor downmodulation. Virology. 234:1997;340-348.
37. Brandt S.M., Mariani R., Holland A.U., Hope T.J., Landau N.R. Association of chemokine-mediated block to HIV entry with coreceptor internalization. J. Biol. Chem. 277:2002;17291-17299.
38. + cells is mediated by the chemokine receptor CC-CKR-5. Nature. 381:1996;667-673.
39. Frey S., Marsh M., Gunther S., Pelchen-Matthews A., Stephens P., Ortlepp S., Stegmann T. Temperature dependence of cell-cell fusion induced by the envelope glycoprotein of human immunodeficiency virus type 1. J. Virol. 69:1995;1462-1472.
40. Fu Y.K., Hart T.K., Jonak Z.L., Bugelski P.J. Physicochemical dissociation of CD4-mediated syncytium formation and shedding of human immunodeficiency virus type 1 gp120. J. Virol. 67:1993;3818-3825.
41. Campbell S.M., Crowe S.M., Mak J. Lipid rafts and HIV-1: from viral entry to assembly of progeny virions. J. Clin. Virol. 22:2001;217-227.
42. + T cells. J. Virol. 76:2002;4709-4722.